Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lucentis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

Novartis launches another localised NHS eye service in UK

Novartis launches another localised NHS eye service in UK Novartis' main product in the area is Lucentis, which is recommended by the National Institute for Health and Care Excellence (NICE) to treat wet AMD – the leading cause of blindness in ... Novartis gained a boost in September when it received a UK

Germany's IQWiG delivers bad news for Bayer’s Eylea

Germany's IQWiG delivers bad news for Bayer’s Eylea Says drug provides no additional benefit over Novartis’ rival Lucentis in eye condition.  . ... Germany's cost-effectiveness watchdog has concluded that Bayer's Eylea provides no additional benefit over Novartis' rival drug Lucentis in patients with a

Novartis partners with NHS on eye service

Novartis partners with NHS on eye service Novartis' interests in the area lie in Lucentis (ranibizumab), which is recommended by the National Institute for Health and Care Excellence (NICE) to treat wet AMD among other eye conditions. ... Novartis gained a boost in September when it received a

Strong sales in breast cancer lift Roche revenues

Strong sales in breast cancer lift Roche revenues Avastin. Oncology. 4, 749. Herceptin. Oncology. 4, 670. Lucentis. Ophthalmology. 1, 260.

Novartis expands eyecare partnership with NHS

Novartis expands eyecare partnership with NHS And wins new licence for Lucentis. Pharma company Novartis has teamed up with the NHS in Wales to launch a new eyecare clinic that will allow 100 more patients to be ... This means the recommended regimen for Lucentis is now one injection per month for

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

Measures for measures
Why pharma’s marketing metrics must close the loop...
Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...

Infographics